Eduardo Bruno Martins

Eduardo Bruno Martins discloses dealings in Sagimet Biosciences Inc. to SEC (Form 4). Between 17 November 2023 and 19 February 2026, the trades on record add up to 6 filings.

On the market, this insider has only sold: 3 sales, €105k in total. The rest of the record consists of 3 share grants. In 2026 alone, the filings show no purchases and 1 sale.

On 20 February 2026 came the latest disclosure, a share grant in Sagimet Biosciences Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.